Together we will beat cancer

Donate

Let’s talk about HPV: 6 common questions answered

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

Read More

HPV vaccine reduces cervical cancer risk

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

Read More

Less regular cervical screening could benefit women, study suggests

Extending the gap between cervical screening tests from five to 10 years is safe for women who test negative for the human papillomavirus (HPV).

Read More

Cervical cancer screening in England to use ‘more accurate’ viral DNA test

The NHS cervical screening programme in England will switch to first testing women for signs of infection with the virus that causes cervical cancer.

Read More

Healthcare staff think gay and bisexual men should be given HPV jab

Around two-thirds of professionals who work in sexual health think the human papillomavirus (HPV) jab should be given to men who have sex with men

Read More

Mouth cancer now the tenth most common cancer in men

Oral cancer is now the tenth most common cancer in men according to new figures released by Cancer Research UK today.

Read More

Oral rinses could help monitor patients with HPV-linked throat cancer

Traces of DNA from the human papillomavirus found in oral rinses could lead to a way to track how throat cancer responds to treatment.

Read More

Anal cancer rates quadrupled since mid 70s

Anal cancer rates in the UK have increased by nearly 300 per cent over the last 40 years, according to new figures published by Cancer Research UK.

Read More

Cancer Research UK launches trial to fight cancer caused by a common virus

Cancer Research UK’s Drug Development Office (DDO) has launched a vaccine trial to treat some forms of cancer caused by the Epstein Barr Virus (EBV).

Read More

Developing a vaccine for the Epstein-Barr Virus could prevent up to 200,000 cancers globally say experts

A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.

Read More